Kailera Therapeutics, Inc. share price logo

Kailera Therapeutics, Inc.

NASDAQ: KLRA

Mid Cap

$13.94

-0.97

(-6.51%)

as on

Kailera Therapeutics, Inc. Stock Performance

as on September 14, 2026 at 2:16 pm IST

  • Day's Low

    Day's High

    $13.95
    $15.27
    downward going graph

    -0.07%

    Downside

    9.54%

    Upside

    downward going graph
  • 52 Week's Low

    52 Week's High

    downward going graph

    100.00%

    Downside

    -100.00%

    Upside

    downward going graph

Kailera Therapeutics, Inc. share price movements today

Previous Close
$14.91
Open
$14.92
Volume
822.5K
Market Cap
$2.1B
Day's Low - High
$13.95 - $15.27

Kailera Therapeutics, Inc. Historical Returns

1 Month Return
-21.81 %
3 Month Return
-22.47 %
1 Year Return
0 %
3 Year Return
0 %
5 Year Return
0 %

Kailera Therapeutics, Inc. Stock Fundamentals & Key Indicators

Check Kailera Therapeutics, Inc. market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$2.1B

EPS (TTM)

-1.76

Dividend Yield

0.00%

PE Ratio (TTM)

-8.43

Industry PE ratio

-13.83

PEG Ratio

-0.08431818181818182

Return On Equity TTM

-55.41%

Kailera Therapeutics, Inc. Stock Valuation

Track how Kailera Therapeutics, Inc. P/E has moved over time to understand its valuation trends.

Kailera Therapeutics, Inc. in the last 1 year

  • Overview

  • Trends

Lowest (-20.63x)

December 31, 2025

Today (-20.63x)

December 31, 2025

Industry (-13.83x)

December 31, 2025

Highest (-20.63x)

December 31, 2025

LowHigh

Today’s Price to Earnings Ratio: -20.63x

Kailera Therapeutics, Inc. vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Kailera Therapeutics, Inc. with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %Dividend Yield %
StrongBuy$2.1BNA-8.430.00%NA
BUY$44.6B614.61%NA0.00%NA
BUY$138.4B181.2%30.5486.04%NA
BUY$56.0B-69.82%-16.99-12.57%NA
BUY$85.2B24.16%19.2884.86%45.660000000000004%

Analyst Recommendation on Kailera Therapeutics, Inc. Stock

Based on 4 analysts

BUY

100.00%

Buy

0.00%

Hold

0.00%

Sell

Based on 4 analysts, 100% of analysts recommend a 'BUY' rating for Kailera Therapeutics, Inc.. Average target price of $45

Indian Investors' Interest in Kailera Therapeutics, Inc. Stock

Search interest for Kailera Therapeutics, Inc. Stock has increased by 94% in the last 30 days, reflecting an upward trend in search activity.

Time period: to

Change:94% versus previous 30 day period

Kailera Therapeutics, Inc. Quarterly Profit & Loss

All numbers in Millions USD

Mar 2026
Jun 2026
Total Revenue
-
-
Gross Profit
-
-
Operating Income
-84
-121
EBITDA
-84
-111
Interest Expense
-
-
Depreciation
0
-
Income Before Tax
-78
-111
Income Tax Expense
-
-
Net Income
-78
-111
Net Profit Margin
0.00%
0.00%

Kailera Therapeutics, Inc. Annual Profit & Loss

All numbers in Millions USD

Dec 2025
Total Revenue
-
Gross Profit
-
Operating Income
-158
EBITDA
-158
Interest Expense
-
Depreciation
0
Income Before Tax
-148
Income Tax Expense
-
Net Income
-148
Net Profit Margin
0.00%

Kailera Therapeutics, Inc. Quarterly Cash Flow

All numbers in Millions USD

Mar 2026
Jun 2026
Net Income
-78
-111
Operating Cash Flow
-68
-77
Investing Cash Flow
22
-571
Financing Cash Flow
-2
667
Change in Cash
-48
18

Kailera Therapeutics, Inc. Annual Cash Flow

All numbers in Millions USD

Dec 2025
Net Income
-148
Operating Cash Flow
-120
Investing Cash Flow
-492
Financing Cash Flow
598
Change in Cash
-14

Mutual Funds that own Kailera Therapeutics, Inc. Stock

Check out the Mutual Funds with significant holdings in Kailera Therapeutics, Inc..

Funds
Holdings
Shares Held
VANGUARD SPECIALIZED FUNDS
1.640854%
2127264
Fidelity Securities Fund
0.630726%
817697
Federated Hermes Equity Funds
0.385672%
500000
HARTFORD MUTUAL FUNDS, INC
0.145165%
188198
Franklin Strategic Series
0.112913%
146385

Global Institutional Holdings in Kailera Therapeutics, Inc.

Funds
Holdings
Vanguard
2.55%
iShares
1.32%
Andrew J.M. Spokes
0.85%
Schwab
0.17%
SPDR
0.15%

Insights on Kailera Therapeutics, Inc.

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgNEGATIVE IMPACT

    Price Dip

    img

    In the last 7 days, KLRA stock has moved down by -14.1%

About Kailera Therapeutics, Inc.

Kailera Therapeutics, Inc. operates as a clinical-stage biopharmaceutical company developing therapies for obesity and related conditions. The company develops clinical- and preclinical-stage therapies, with a product pipeline that includes injectable peptides, oral peptides, and oral small molecules. Key programs include KAI-9531, an injectable GLP-1/GIP receptor dual agonist; KAI-7535, an oral small molecule GLP-1 receptor agonist; and KAI-4729, an injectable GLP-1/GIP/glucagon receptor tri-agonist. Kailera Therapeutics holds exclusive rights for global development and commercialization of four metabolic disease assets outside of Greater China, with therapies delivered through oral and injectable formulations. The company was founded in 2024 and is based in Waltham, Massachusetts.
OrganisationKailera Therapeutics, Inc.
Headquarters180 Third Avenue, Waltham, MA, United States, 02451
IndustryBiotechnology
CEOMr. Ronald C. Renaud Jr., M.B.A.
E-voting on sharesClick here to vote

Key Management of Kailera Therapeutics, Inc.

Name

Title

Ms. Jamie Beth Coleman

Chief Commercial Officer

Mr. Scott M. Akamine J.D.

Chief Legal Officer & Secretary

Ms. Kathleen Tregoning M.A.

Chief Corporate Affairs Officer

Dr. Scott M. Wasserman M.D.

Chief Medical Officer

Mr. Corey Manchester

Treasurer

Mr. Ronald C. Renaud Jr., M.B.A.

President, CEO & Director

Mr. Paul Douglas Burgess J.D., M.S.

Chief Operating & Business Officer

Mr. Douglas W. Pagan M.B.A.

Chief Financial Officer

Maura Gavaghan

Vice President of Corporate Communications & Investor Relations

Ms. Paula A. Cloghessy SHRM-SCP, SPHR

Chief People Officer

FAQs

What is Kailera Therapeutics, Inc. share price today?

Kailera Therapeutics, Inc. share price today is $13.94 as on at the close of the market. Kailera Therapeutics, Inc. share today touched a day high of $15.27 and a low of $13.95.

What is the 52 week high and 52 week low for Kailera Therapeutics, Inc. share?

Kailera Therapeutics, Inc. share touched a 52 week high of $0.00 on and a 52 week low of $0.00 on . Kailera Therapeutics, Inc. stock price today i.e. is closed at $13.94,which is -Infinity% down from its 52 week high and Infinity% up from its 52 week low.

What is Kailera Therapeutics, Inc.'s market capitalisation today?

Kailera Therapeutics, Inc. market capitalisation is $0.00T as on .

How to invest in Kailera Therapeutics, Inc. Stock (KLRA) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Kailera Therapeutics, Inc. on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Kailera Therapeutics, Inc. Shares that will get you 0.1076 shares as per Kailera Therapeutics, Inc. share price of $13.94 per share as on September 14, 2026 at 8:46 am IST.

What is the minimum amount required to buy Kailera Therapeutics, Inc. Stock (KLRA) from India?

Indian investors can start investing in Kailera Therapeutics, Inc. (KLRA) shares with as little as ₹95.55 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹955.50 in Kailera Therapeutics, Inc. stock (as per the Rupee-Dollar exchange rate as on ). Based on Kailera Therapeutics, Inc. share’s latest price of $13.94 as on September 14, 2026 at 8:46 am IST, you will get 0.7174 shares of Kailera Therapeutics, Inc.. Learn more about fractional shares .